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Abstract: Boldenone undecylenate (BOL) is an anabolic androgenic steroid used in livestock to improve 
growth and food conversion. This study investigated the actions of BOL on structure and functions of rabbit 
liver as well as the effects of its withdrawal. Eighteen mature male New Zealand rabbits were divided into 
2 groups: Control group (n=6) were injected with 0.25 mL corn oil/kg body weight (BW), while BOL group 
(n=12) received 3 intramuscular injections, 2 wk apart, of BOL (4.5 mg/kg BW). Animals were scarified 1 d 
after last injection except for 6 rabbits from BOL group that served as the BOL-withdrawal group (4 wk 
after the 3rd injection). Intramuscular injection of BOL increased (P<0.05) malondialdehyde (MDA) level, but 
markedly lowered activities of superoxide dismutase (SOD) and catalase (CAT) and reduced glutathione 
(GSH) concentration compared to both control and BOL-withdrawal groups. Treatment with BOL significantly 
(P<0.05) increased serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) 
compared to the control group. BOL injection caused different histopathological alterations and apoptosis 
in liver, but these changes were less evident in the BOL-withdrawal group. Expression of p53 and tumour 
necrosis factor-α (TNF-α) genes was up regulated in BOL compared to control group, while the expressions of 
p53 and TNF-α were down regulated in BOL-withdrawal group in comparison with BOL group. In conclusion, 
BOL injection induced structural and functional changes in the liver of rabbits, increasing oxidative stress 
and mediators of apoptosis such as ROS, p53 and TNF-α. All these parameters returned to near the control 
values after withdrawal.
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introduction
Anabolic androgenic steroids (AAS) are synthetic derivatives of male sex hormone, testosterone, that have been 
modified to improve its anabolic rather than androgenic activity. The AAS promote protein synthesis, muscle growth, 
and erythropoiesis and thus are used to enhance strength and endurance in canine, equine and human athletes via 
increasing muscle protein production (Guan et al., 2010).  
Boldenone (1,4-androstadiene-17beta-ol-3-one; BOL) and its precursor boldione (1,4-androstadiene-3-17dione) are 
testosterone derivatives used as synthetic anabolic androgenic steroids in livestock under the trade names Equipoise, 
Ganabol, Equigan and Ultragan (Cannizzo et  al., 2007). BOL, which exhibits a strong anabolic and moderately 
androgenic property, is used mainly as undecylenate ester by bodybuilders but is also administered illegally to 
racehorses (Soma et al., 2007). It improves growth and food conversion in food producing animals such as veal 
calves and beef cattle (Kicman, 2008) by promoting positive nitrogen balance and protein synthesis and reducing 
protein catabolism. In addition, BOL induces retention of body water, nitrogen, sodium, calcium, and potassium ions. 
In most countries worldwide, this anabolic steroid is forbidden for meat production and human uses (Cannizzo et al., 
2007). Misuse of AAS causes several adverse health effects such as liver dysfunction (Amsterdam et al., 2010), 
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tendon damage (Battista et al., 2003), disturbance of endocrine and immune functions, sebaceous system and skin 
alterations and changes of the haemostatic system and urogenital tract (Hartgens and Kuipers, 2004). 
To our knowledge, there are relatively few studies investigating the detrimental effects of BOL administration on 
the hepatic antioxidant defence mechanism as well as on the enhancement of pro-inflammatory cascades and 
the induction of apoptosis in the liver. Therefore, this study was carried out to evaluate the hepatotoxic effects 
of BOL injection in rabbits as well as the effects of its withdrawal through estimation of serum concentrations of 
hepatic transaminases, antioxidant enzyme activities, histopathological examination of liver and determination of the 
expression levels of tumor protein p53 and tumor necrosis factor (TNF-α) genes using semi-quantitative RT-PCR.  
Material and Methods
Animals
Eighteen apparently mature New Zealand male rabbits weighing 2.8-3.5 kg and 5- to 6-mo old were obtained from 
the Laboratory Animal farm at the Faculty of Veterinary Medicine, Zagazig University, Egypt. Animals were housed 
separately in metal cages and left to acclimatise for 2 wk before the experiment. Pelleted commercial feed (Abou 
Amer Co., Cairo, Egypt) and water was supplied ad libitum. The experimental protocol was approved by the ethical 
committee of Cairo University and the experimental procedures were performed according to the guidelines of the 
National Institutes of Health for the care and use of laboratory animals.
Chemicals
Equi-gan® vial was purchased from Laboratorios Tornel, Co., S.A. Mexico.  
Experimental design
After 2  wk of acclimatisation, rabbits were divided into 2  groups, control (n=6) and BOL-treated group (n=12). 
The control group was injected with i.m. corn oil (vehicle) in a dose of 0.25 mL/kg BW. The treated group received 
3 intramuscular injections of BOL (4.5 mg/kg BW) 2 wk apart, for 4 wk. The dose of BOL was selected according to 
Paget and Barnes (1964). Six rabbits from the BOL group were withdrawn from the experimental treatment and served 
as the BOL withdrawal group (4 wk after the 3rd injection). Rabbits of control and BOL groups were sacrificed 1 d after 
the last injection of vehicle and BOL respectively, while rabbits of the withdrawal group were sacrificed 4 wk later.
Biochemical investigations
After decapitation, blood samples were collected from jugular vein and centrifuged at 3000  rpm for 15  min to 
separate serum which was stored at –20°C until biochemical analyses. Activities of serum alanine transaminase (ALT) 
and aspartate transaminase (AST) were determined spectrophotometrically using commercial diagnostic kits provided 
from Biodiagnostic Co. (Giza, Egypt). After dissection, the livers were removed and weighed with the attached fat 
trimmed off. Some samples were homogenised (10% w/v) in potassium phosphate buffer solution (pH 7.4) and 
centrifuged at 3000 rpm for 15 min. The resulting supernatant was used to determine the parameters of oxidative 
status using assay kits of catalase (CAT; CAT100-1KT) and superoxide dismutase (SOD; 19160-1KT-F), glutathione 
(GSH; CS0260-1KT) and lipid peroxidation by malondialdehyde (MDA; MAK085-1KT) provided by Sigma (St. Louis, 
MO, USA). Other liver samples were immediately frozen in liquid nitrogen for the determination of p53 and TNF-α gene 
expressions using semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).
Histopathological examination
Liver specimens were fixed in 10% neutral buffered formalin, processed and stained with hematoxylin and eosin dyes 
for standard histopathological examination using light microscope 
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Expression levels of liver p53 and TNF-α mRNAs
Total RNA was extracted from liver tissue using protocol provided by RNeasy Mini Kit, Cat. No. 74104 (Qiagen, Heidelberg, 
Germany). The amount of RNA extracted was quantified and qualified using NanoDrop® ND-1000 Spectrophotometer 
(NanoDrop Technologies, Wilmington, Delaware USA). Only high purity samples (OD 260/280 >1.8) were further 
used. 
One µg of total RNA was reverse transcribed into cDNA using Qiagen 2Step RT-PCR Kit, Cat. No. 205920 following 
the manufacturer instructions in a 20 µL total volume. 
The mixture contained 2 μL cDNA, 0.2 mM of each dNTP, and the Taq polymerase buffer which contained 10 mM 
Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 7.5 pM of each primer (Table 1) and 1.5 U of Taq polymerase was placed 
in a 2720  thermocycler (Applied Biosystems, USA). Expression was normalised by glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) gene expression which was used as an internal housekeeping control. PCR amplification 
conditions were as follows: denaturation at 95°C for 4 min followed by 28 cycles of 95°C, 1 min; 55°C, 1 min; 72°C, 
1 min for TNF-α and annealing temp. 58°C for p53 and GAPDH. The 10 μL of PCR products were analysed on 2% 
agarose gel stained with ethidium bromide in 1× Tris acetate ethylenediaminetetraacetic acid (EDTA) buffer (TAE, Tris 
0.04 M, acetate 0.04M, EDTA, 0.001M), pH 8.3-8.5 (Stock solution was 50× from Bioshop® Canada Inc. Burlington). 
The electrophoretic picture was visualised by gel documentation system (Bio Doc Analyze, Biometra, Germany). The 
expression levels of the gene bands intensity on gel were analysed by use of Image J software (version 1.24).
Statistical analysis 
The results were expressed as mean±standard error (SE). The data were analysed for a statistical significance 
between the control and treated groups by one-way analysis of variance (ANOVA) using IBM SPSS Statistics computer 
program (version 21). P-Values lower to 0.05 were considered statistically significant.
results
Biochemical analyses
Serum ALT and AST activities were significantly (P<0.05) 
increased in rabbits injected with BOL in comparison to 
control group. In the BOL-withdrawal group, their levels 
were lower than those of the BOL group, but still higher 
than those of controls (Figure 1). The hepatic SOD and 
CAT activities and GSH concentration were significantly 
decreased in BOL group, while MDA concentration was 
significantly elevated in comparison to control group 
(Table 2). The BOL-withdrawal group showed an increase 
(P<0.05) in hepatic SOD and CAT activities and GSH 
content and a decrease (P<0.05) in MDA concentration 
when compared to the BOL group (Table 2). 
Histopathological examination
The liver of control rabbits revealed normal and intact 
hepatocyte and sinusoidal architectures (Figure 2A), while 
that of BOL group showed focal areas of coagulative 
necrosis. The latter were partially replaced by lymphocytes 
(Figure 2B) or lymphocytes and extravasated erythrocytes 
(Figure 2C). In addition to focal haemorrhages, congestion 
of hepatic blood vessels and sinusoids was also noticed 
(Figure 2D). Hydropic degeneration and vacuolations in the 
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Figure 1: Effect of BOL i.m. injection on serum alanine 
aminotransferase (ALT) and aspartate aminotransferase 
(AST) concentrations of male New Zealand rabbits 
(mean±standard error, n=6). Bars carrying different 
letters are significantly different at P<0.05. 
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hepatocytes were widely spread in the hepatic lobules, in addition to activation of apoptosis with numerous apoptotic 
bodies throughout the hepatic parenchyma (Figure 2E). The portal areas showed mild to moderate hyperplasia in the 
lining epithelium of bile ducts and few lymphocyte infiltrations (Figure 2F). In comparison with the above-mentioned 
BOL group findings, the liver of BOL-withdrawal group revealed milder lesions with intact hepatic cells and cords. Mild 
vacuolations in the cytoplasm of some hepatocytes were observed (Figure 2G). Sometimes, the portal areas showed 
few lymphocyte infiltrations with no evidence of the hyperplasia in biliary epithelia (Figure 2H). 
Expression levels liver p53 and TNF-α mRNAs
The expression of p53 and TNF-α mRNAs in liver of BOL group was up regulated in comparison to control group, while 
that of the BOL-withdrawal group was down regulated compared to BOL-treated one. The GAPDH gene almost show 
stable patters in all group (Figure 3).
discussion
The results revealed that BOL injection in rabbits induced liver dysfunction, indicated by significant elevation in serum 
transaminases activities (AST and ALT) compared to the control group. Our results are in agreement with previous 
studies (El-Moghazy et  al., 2012; Tousson et  al., 2013). Moreover, similar results were recorded on AAS abuse 
(Urhausen et al., 2003). These results are also consistent with Welder et al. (1995) who cited that AAS have toxic 
effects in primary rat hepatic cultures. Controversially, Molano et al. (1999) reported that prolonged administration 
of anabolic steroid stanozolol had no significant effect on classical serum markers of liver function. The increment in 
serum AST and ALT activities may be attributed to the release of these enzymes from the cystol of liver cells into the 
blood circulation as a result of hepatocytes damage (Navarro et al., 1993). The activity of hepatic enzymes showed 
a significant reduction during the withdrawal period compared to BOL group and returned to near the control values. 
These findings are consistent with the suggestions of Peters et al. (1997) that elevation in liver enzymes usually tend 
to return to normal once the drug is stopped and with the findings of Urshausen et al. (2003) who found that the 
negative effects of massive consumption of AAS on liver function were restored to normal after discontinuation of 
abuse. 
Our results showed a significant increase in MDA level and markedly lowered activities of SOD, CAT and GSH 
concentrations in BOL rabbits compared to those of control rabbits. These results support the findings of El-Moghazy 
Table 2: Effects of BOL injection on MDA and GSH concentrations and the antioxidant enzyme activities (SOD and CAT) 
in the liver of male New Zealand rabbits (mean±standard error, n=6).
Parameters  
Groups  
MDA 
(µmol/g tissue)
SOD 
(U/mg protein)
CAT  
(µmol H2O2 decomposed/g tissue)
GSH 
(mg/g tissue)
Control 10.99±0.22c 2.80±0.10a 147.50±0.01a 16.13±1.40a
BOL 16.81±0.49a 1.70±0.30c 145.00±0.01c 7.03±0.66c
BOL-withdrawal 13.10±0.18b 2.20±0.01b 146.00±0.01b 14.13±1.20b
MDA: malondialdehyde. SOD: superoxide dismutase. CAT: catalase. GSH: reduced glutathione.
Means within the same column having different superscripts are significantly different at P<0.05.
Table 1: Oligonucleotide primers used for semi-quantitative RT-PCR analysis of GAPDH, p53, and TNF-α genes.
Gene Sequence Product size/pb References
GAPDH Forward: 5’ ACCACAGTCCATGCCATCAC -3’ 
Reverse: 5’CTGGAAGATGGTGATGGGTT-3’
455 Jones et al., 1995
p53 Forward: 5’TCATCTTGGGCCTGTGTTATCT-3’ 
Reverse: 5’GTGCAGGGTGGCAAGTGG-3’
332 Bromidge and Howe, 2000
TNF-α Forward: 5’CTCAGCCTCTTCTCAICTTCC3’ 
Reverse: 5’GCAGAGAGGAGGTTGACT/CT3’
421 Farges et al., 1995
GAPDH: glyceraldehyde 3-phosphate dehydrogenase.
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Figure 2: Photomicrographs of rabbit liver from: A: control shows normal hepatocyte and sinusoidal architectures. (B-
F): BOL- treated group shows: B: coagulative necrosis (arrow) with lymphocyte infiltrations (arrowhead) and hydropic 
degeneration (short arrows). C: lymphocytes and erythrocytes replaced the necrosis (arrows). D: congestion of hepatic 
sinusoids and haemorrhage (arrows). E: numerous apoptotic bodies throughout the hepatic parenchyma (arrows). F: 
portal area with hyperplasia in the lining epithelium of bile ducts (arrow) and few lymphocyte infiltrations (arrowhead). 
(G and H): BOL- withdrawal group shows: G: vacuolations in the hepatocytes (arrows).  H: portal area with lymphocyte 
infiltrations (arrow) besides normal bile duct (arrowhead). HE (Bar=100 µm).
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et al. (2012) who reported that BOL injection in rabbits 
caused hepatic oxidative stress. These findings are also 
concordant with previous studies by Sadowska-Krepa 
et al. (2011), where they cited that AAS treatment induced 
oxidative stress in rats. The ability of BOL to induce 
lipid peroxidation supports the hypothesis of Langfort 
et  al. (2010) that testosterone, by elevating hormone-
sensitive lipase activity and stimulating the lipolysis of rat 
cardiomyocytes, enhances the availability of long chain 
fatty acids for ATP synthesis which, in turn, elevates 
oxygen utilisation and thus enhances reactive oxygen 
species (ROS) generation. Interestingly, the withdrawal of 
BOL for 4 wk after the last injection restored the hepatic 
oxidative stress markers to near the control values.
The biochemical parameters confirmed the liver 
histopathological findings. The histopathological 
examination of liver of BOL group revealed coagulative 
necrosis with lymphocytic infiltration, congestion of 
hepatic blood vessels, hydropic degeneration and 
vacuolations of hepatocytes, as well as activation of 
apoptosis and numerous apoptotic bodies throughout the 
hepatic parenchyma. These findings are in agreement 
with those of El-Moghazy et al. (2012) who reported that 
intramuscular injection of BOL to rabbits has a marked 
adverse effect on hepatic structure. Similar changes 
in hepatic tissue of cattle have been reported by Groot 
and Biolatti (2004). These pathological changes became 
milder in BOL-withdrawal group.
The histopathological lesions were correlated with 
expression of p53  and TNF-α genes which was up 
regulated in BOL rabbits compared to the control group. 
Our results are in line with that described by Tousson 
et al. (2011), who reported an increase in the expression 
of p53 after BOL injection in rabbits. These findings are 
also in agreement with Du Toit et al. (2005) who found 
that AAS increased levels of TNF-α in myocardial tissue 
in basal and post ischemic periods. Moreover, exogenous 
androgen supplementation has been indicated to increase 
apoptosis in rat ventricular myocytes (Zauyg et al., 2001). 
Moreover, our findings also revealed that the expression 
level of p53 and TNF-α genes was down regulated in the 
BOL-withdrawal group compared to BOL.
The p53 proved to have regulatory responses to a variety 
of cellular stressors including DNA damage, nucleotide 
depletion, chemotherapeutic drugs, oxidative stress, 
genotoxic damage, oncogene activation and hypoxia 
(Grawish, 2008). These stressors can trigger p53  to 
induce cell growth arrest or apoptosis, as p53 regulates 
the transcription rate of some different genes responsible 
for cell cycle regulation, DNA repair and apoptosis (Wang 
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Figure 3: The expression level of mRNAs of  A: p53, 
B: TNF-α  and C: GAPDH genes in the liver tissue of 
male New Zealand rabbits. M; DNA marker (100 pb), 
lane 1; control group, lane 2; BOL- treated group, lane 
3; The BOL- withdrawal group. GAPDH: glyceraldehyde 
3-phosphate dehydrogenase.
Boldenone-induced apoptotic, structural, and functional alterations in the liver of raBBits 
45World Rabbit Sci. 23: 39-46
et al., 2005). p53 was associated with the production of oxygen radicals (Buzek et al., 2002). p53 is implicated in 
the activation of aspartate-specific cysteine proteases (caspases) that mediated apoptosis. One of the signalling 
pathways by which p53 induce apoptosis is the engagement of particular (death) receptors that belong to the tumour 
necrosis factor receptor (TNF-R) family (Ashkenazi and Dixit, 1998). Moreover, TNF-α is a cytokine capable of initiating 
a broad range of biological effects, including apoptosis of some tumour cells (Wong et al., 1997). These effects are 
mediated through TNF receptor oligomerisation, which activates a caspase cascade through cytoplasmic proteins and 
TNF-receptor complexes. Therefore, all these results suggest that BOL could induce inflammatory cascades in liver. 
Furthermore, TNF-α has been shown to induce apoptosis and accumulation of p53 in various cell types, suggesting 
the potential involvement of p53 in TNF-α-induced cell death, as previously reported in prostate carcinoma cell line 
LNCaP (Rokhlin et al., 2000). 
conclusion
Our data suggest that the anabolic androgenic steroid BOL induced hepatotoxicity in rabbits through induction of 
some mediators of apoptosis such as ROS, p53, and TNF-α which interplay together and resulted in alterations in the 
function and structure of hepatic tissue. However, these alterations were restored to near the control levels after its 
withdrawal. In addition, misuse of this drug may contribute to continuous damage of hepatic function and structure 
that may lead to a progressive liver injury. 
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